Kamada (KMDA)

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

的Kamada Ltd. Ordinary Shares（KMDA）股票after-hours的价格今天是$9.03，自市场最后关闭以来，反映出+3.79%after-hours的变动。该公司市值为$5.21亿，日交易量为$5.44万股。对于关注价格走势的投资者来说，Kamada Ltd. Ordinary Shares股票今日的波动区间在$8.91和$9.09之间。前一交易日收盘价为 $8.70。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Kamada股票的指南。